Protalix BioTherapeutics logo
Protalix BioTherapeutics PLX
$ 1.71 2.71%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Protalix BioTherapeutics EV/EBITDA Ratio 2011-2024 | PLX

Annual EV/EBITDA Ratio Protalix BioTherapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-2.1 45.9 -9.68 -4.08 -2.66 -2.44 -3.59 -9 -16.3 -47.7 -13.2

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
45.9 -47.7 -5.9